89bio, Inc. (ETNB) Misses Q3 EPS by 77c

89bio, Inc. (NASDAQ: ETNB) reported Q3 EPS of ($1.39), $0.77 worse than the analyst estimate of ($0.62).

For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Super Micro Computer establishes $1.25 billion stock sale agreement
• Triumph Gold closes $5.4 million private placement financing